Mia's Feed
Medical News & Research

Innovative Reversible Technique Targets Neural Circuits with Molecular Precision

Innovative Reversible Technique Targets Neural Circuits with Molecular Precision

Share this article

A pioneering technique enables reversible, precise disruption of brain neural circuits using engineered proteins, opening new avenues for neuroscience research and potential therapies for neurological disorders.

2 min read

Scientists at USC Dornsife have developed a groundbreaking method that allows for the precise, reversible disconnection of specific neural pathways in the brain. This advance, detailed in the journal eLife, introduces specialized genetically engineered tools capable of selectively eliminating either excitatory or inhibitory synapses—the critical junctions where neurons communicate—without affecting the entire neuron. This level of specificity is unprecedented in neuroscience, as it enables researchers to study the microcircuits that underpin perception, behavior, and memory with unparalleled accuracy.

The technique employs E3 ligases, enzymes involved in the cell’s protein recycling, which tag proteins at synapses for degradation. Paired with antibody-like molecules that bind to synaptic scaffolding proteins, these tools direct the brain's natural proteasome system to selectively dismantle chosen synapses. Named PFE3 and GFE3, these tools target excitatory and inhibitory synapses, respectively, and can be activated by light or chemical signals. Crucially, the destruction of synapses is reversible; turning off the tools allows neurons to regrow the lost connections within days, enabling dynamic exploration of neural circuit function.

This innovation holds promise for advancing our understanding of how brain microcircuits operate and could one day lead to therapies that precisely target dysfunctional neural pathways in conditions like epilepsy, addiction, and PTSD, without damaging surrounding tissues. The research signifies a major leap in neuroengineering, offering scientists a powerful new way to manipulate brain circuits with molecular precision, and the potential for future therapeutic applications.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

promising new investigational treatment shows potential for Crohn's disease remission

A new investigational therapy targeting TL1A shows significant potential to induce remission in Crohn's disease, offering hope for better treatment options. Recent studies highlight rapid response and possible effects on fibrosis crucial in disease management.

Revealing the 3D Structure of Human Clusterin and Its Implications for Alzheimer's Disease

New structural insights into human clusterin reveal its role in preventing protein aggregation linked to Alzheimer's disease, opening new avenues for therapeutic research.

Innovative AI Techniques Reveal How We Make Decisions

New AI-based research uncovers the actual decision-making strategies of humans and animals using small, interpretable neural networks, offering insights into suboptimal and individual strategies in real-world scenarios.

Breakthrough Genetic Research Spurs Large-Scale Diabetes Trials in Chinese Hospitals

A groundbreaking genetic study in China has led to the development of a new diagnostic tool for more accurate classification of diabetes types, paving the way for large-scale clinical trials and personalized treatment approaches.